Brief: Lipigon Pharmaceuticals: Application For Development Support From European Innovation Council Denied
16/07/2024 15:46
July 16 (Reuters) - Lipigon Pharmaceuticals AB
LPGO.ST :
* LIPIGON'S APPLICATION FOR DEVELOPMENT SUPPORT FROM THE
EUROPEAN
INNOVATION COUNCIL IS DENIED
Source text for Eikon: ID:nBQN4Vt2bf
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds